Clinical Maestro Launches Source Plus, the Intelligence Layer for Clinical Sourcing
BOSTON, MA, September 10, 2026 (EZ Newswire) -- Clinical Maestro launches Source Plus, its next-generation intelligent
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.
BOSTON, MA, September 10, 2026 (EZ Newswire) — Clinical Maestro launches Source Plus, its next-generation intelligent sourcing solution for pharmaceutical and biotechnology organizations managing complex, high-value outsourced services.
Source Plus goes beyond traditional sourcing automation by combining Maestro AI, pharmaceutical domain intelligence, proven sourcing methodologies, structured data and highly configurable workflows into a single intelligence layer. Unlike generic procurement applications designed primarily for standardized purchasing, Source Plus is purpose-built for complex clinical outsourcing decisions where service providers may differ substantially in scope, assumptions, timelines, activities, delivery models and pricing.
From a focused RFI to a global, multi-region and multi-cohort clinical RFP, Source Plus helps teams structure requirements, engage service providers, compare sophisticated proposals, manage negotiations and make faster, better-supported outsourcing decisions.
“Clinical sourcing is fundamentally different from generic procurement,” said Anca Copaescu, chief executive officer of Clinical Maestro. “These are complex, high-value decisions that require much more than comparing price. Source Plus combines Maestro AI with nearly a decade of pharmaceutical outsourcing know-how, proven methodologies and clinical-specific workflows to create an intelligence layer around the sourcing decision. It turns complexity into structured, actionable intelligence.”
Intelligence Beyond AI
Artificial intelligence is an important part of Source Plus and further enhances the intelligence that already constitutes the intelligence layer of the application: industry best practices, unique clinical know-how and workflows and bid grid mapping. Further, Source Plus combines Maestro AI for natural-language retrieval, event creation, proposal analysis and executive summaries with pharmaceutical intelligence built around clinical terminology, study assumptions, timelines, detailed budgets and service provider proposals. Proven sourcing methodologies are embedded into reusable, configurable workflows, while structured data transforms sourcing history into organizational knowledge that can be retrieved, compared and reused.
Instead of leaving valuable information trapped in spreadsheets, documents and individual team members, Source Plus turns sourcing activity into reusable domain-specific intelligence.
Built for Complex Sourcing Decisions
Pharmaceutical sourcing requires flexibility and analytical depth that generic procurement technology was not designed to provide. Source Plus enables teams to evaluate not only total price, but the assumptions and operational decisions behind it, including scope, activities, effort, timelines, delivery models, rates, cohorts, regions and negotiation rounds.
Its component-based architecture allows organizations to standardize sourcing without forcing every project into the same workflow. Teams can create anything from a streamlined RFI to a sophisticated global RFP, reuse templates and components, and apply different costing methodologies within the same event.
“Our objective was to build technology capable of handling pharmaceutical complexity without making the technology itself complex,” said Paulo Carvalho, chief operating officer of Clinical Maestro. “Source Plus combines deep flexibility and configurability with an intuitive user experience and a faster, more secure architecture. It is designed to provide the sophisticated functionality pharmaceutical outsourcing requires while remaining simple for teams to use every day.”
Smarter Sourcing from RFI to Award
Source Plus brings the sourcing journey into one connected environment. Teams can configure events from reusable templates, collect standardized service provider responses in the solution or through familiar Excel templates, compare proposals across assumptions, scope, timelines, activities, scores and detailed costs, and track changes across rebids and negotiations. Maestro AI helps retrieve information, identify meaningful differences and generate decision-ready summaries while keeping users in control.
The solution connects clinical operations, outsourcing, procurement, finance and other stakeholders around a transparent and defensible vendor-selection process. It also extends beyond clinical outsourcing to all major R&D procurement categories, such as CMC, pre-clinical and non-clinical.
From Sourcing Data to Organizational Intelligence
Source Plus creates value beyond an individual RFP. As sourcing events accumulate, proposals, assumptions, pricing, negotiations and service provider responses become structured and searchable. Organizations can reuse that knowledge in future decisions rather than repeatedly rebuilding analyses from disconnected files — turning sourcing history into an increasingly valuable intelligence asset.
Measurable Business Impact
Clinical Maestro customers have demonstrated more than 75% reduction in sourcing effort, more than 50% shorter sourcing cycles and more than 10% savings through the RFP process. Source Plus builds on that foundation with greater flexibility, deeper intelligence, enhanced AI and a modernized enterprise architecture.
The result: Less manual work, more comparable proposals, deeper insight and faster, more confident outsourcing decisions.
About Clinical Maestro
Clinical Maestro develops purpose-built technology for pharmaceutical business operations. Source Plus is its next-generation intelligent sourcing solution, combining Maestro AI, pharmaceutical expertise, structured data and configurable workflows to simplify complex outsourcing and improve decision-making. For more information, visit clinicalmaestro.com.
Media Contact
Ema Hafner
Marketing Director
ehafner@clinicalmaestro.com
SOURCE: Clinical Maestro
